Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:03 PM
Ignite Modification Date:
2025-12-24 @ 11:03 PM
NCT ID:
NCT05874869
Eligibility Criteria:
Inclusion Criteria:
* being afebrile,
* willing to participate in the trial, and
* the ability to swallow oral medications.
Exclusion Criteria:
* a presence of an acute febrile illness or severe illness that impairs the ability to take oral medication
* HIV-positive child receiving cotrimoxazole prophylaxis,
* a child who has received a dose of antimalarial drug including dihydroartemisinin-piperaquine during the past month; and
* a history of allergy to DHA-PQ.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
3 Months
Maximum Age:
59 Months
Study:
NCT05874869
Study Brief:
Protocol Section:
NCT05874869